A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults

NCT ID: NCT05897242

Last Updated: 2025-06-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-04

Study Completion Date

2024-04-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Almost one in ten young adults report current e-cigarette use, putting them at risk of developing nicotine addiction and long-term health effects of exposure to inhaled toxicants. Despite the need for effective treatments to help these young users quit, very few treatments targeting any type of tobacco use among young adults have been evaluated, particularly for young adults who vape and have unique treatment needs. To address these needs, this trial will evaluate a digital program for young adult e-cigarette users at all stages of readiness to quit called ACT on Vaping.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OUTLINE:

Participants are randomized to 1 of 2 arms.

ARM I: Participants use the ACT on Vaping smartphone app and text messaging program and receive incentivized text messages assessing their vaping status.

ARM II: Participants receive incentivized text messages check-ins assessing their vaping status.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nicotine Dependence Nicotine Addiction Nicotine Use Disorder Nicotine Vaping Vaping

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors
Any outcome evaluator who has direct contact with participants will be blinded to treatment assignment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I (Act on Vaping app)

Participants receive supportive messages and use the ACT on Vaping smartphone app. They also receive incentivized text message check-ins assessing their vaping status.

Group Type EXPERIMENTAL

Smartphone app

Intervention Type BEHAVIORAL

Use ACT on Vaping smartphone app

Text Message

Intervention Type OTHER

Receive text messages

Survey Administration

Intervention Type OTHER

Ancillary studies

Arm II (Incentivized text message check-ins)

Participants receive incentivized text messages check-ins assessing their vaping status.

Group Type ACTIVE_COMPARATOR

Text Message

Intervention Type OTHER

Receive text messages

Survey Administration

Intervention Type OTHER

Ancillary studies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Smartphone app

Use ACT on Vaping smartphone app

Intervention Type BEHAVIORAL

Text Message

Receive text messages

Intervention Type OTHER

Survey Administration

Ancillary studies

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ACT on Vaping SMS Text

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-30.
* Current weekly user of e-cigarette product(s).
* Owns an Android phone or iPhone.
* Has an email address.
* United States (US) resident, with a US mailing address.
* Willing to complete all study procedures.

Exclusion Criteria

* Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these treatments is allowable during trial participation).
* Member of the same household as another research participant.
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role collaborator

Fred Hutchinson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jaimee Heffner

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jaimee Heffner

Role: PRINCIPAL_INVESTIGATOR

Fred Hutch/University of Washington Cancer Consortium

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2022-10010

Identifier Type: REGISTRY

Identifier Source: secondary_id

UG3DA057032

Identifier Type: NIH

Identifier Source: secondary_id

View Link

RG1122763

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Adolescent Inpatient Tobacco and ENDS Intervention
NCT05936099 ACTIVE_NOT_RECRUITING NA
Kick-Nic! Youth Quit Vaping App
NCT06662305 RECRUITING PHASE2
Smoking Cessation in Hospitalized Smokers
NCT01289275 COMPLETED PHASE4